Opportunity
NOI; non-competitive combined synopsis solicitatio
Response due
September 23, 2026
- Agency
- National Institutes of Health Olao
- Estimated value
- Not stated
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued.(ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable).This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies.
Key dates
- Posted
- September 14, 2026
- Response due
- September 23, 2026
Who is this buyer
Organization
Buying history
- Records263 total
- Opportunities / awards10 / 20
- Value range$0 – $30,482,226
- ActiveJuly 15, 2026 – October 26, 2026
What they buy
- Clinical (251)
- Administrative (12)
Set-asides used
- No Set aside used (68)
- Small Business Set Aside - Total (14)
Who holds their work today
- EAGLE HEALTH, LLC1 win · $30,482,226 · last February 1, 2020
- LC INDUSTRIES INC1 win · $286,880 · last February 13, 2026
Also open from this buyer
- Clinical Research Support and Collaboration for NHGRI ProtocolsDue November 13, 2026 · Clinical
- NOI - 4D-Nucleofector Core Unit and X UnitDue November 5, 2026 · Clinical
- Reagents and consumables for Roche immunostainersDue October 28, 2026 · Clinical
- Combines Synopsis Solicitation- Automated SpatialDue November 5, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 541715
- PSC
- Q301